337 related articles for article (PubMed ID: 19005583)
21. Class I HLA haplotypes form two schools that educate NK cells in different ways.
Horowitz A; Djaoud Z; Nemat-Gorgani N; Blokhuis J; Hilton HG; Béziat V; Malmberg KJ; Norman PJ; Guethlein LA; Parham P
Sci Immunol; 2016 Sep; 1(3):. PubMed ID: 27868107
[TBL] [Abstract][Full Text] [Related]
22. NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E.
Battin C; Kaufmann G; Leitner J; Tobias J; Wiedermann U; Rölle A; Meyer M; Momburg F; Steinberger P
Immunology; 2022 Aug; 166(4):507-521. PubMed ID: 35596615
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors.
Kamya P; Tallon B; Melendez-Pena C; Parsons MS; Migueles SA; Connors M; Miconiatis S; Song R; Boulet S; Bruneau J; Tremblay CL; Bernard NF;
Clin Immunol; 2012 Jun; 143(3):246-55. PubMed ID: 22445844
[TBL] [Abstract][Full Text] [Related]
24. KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.
Thoens C; Berger C; Trippler M; Siemann H; Lutterbeck M; Broering R; Schlaak J; Heinemann FM; Heinold A; Nattermann J; Scherbaum N; Alter G; Timm J
J Hepatol; 2014 Sep; 61(3):475-81. PubMed ID: 24780303
[TBL] [Abstract][Full Text] [Related]
25. Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients.
Ivison GT; Vendrame E; Martínez-Colón GJ; Ranganath T; Vergara R; Zhao NQ; Martin MP; Bendall SC; Carrington M; Cyktor JC; McMahon DK; Eron J; Jones RB; Mellors JW; Bosch RJ; Gandhi RT; Holmes S; Blish CA;
Front Cell Infect Microbiol; 2022; 12():757846. PubMed ID: 35223535
[TBL] [Abstract][Full Text] [Related]
26. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.
Alter G; Martin MP; Teigen N; Carr WH; Suscovich TJ; Schneidewind A; Streeck H; Waring M; Meier A; Brander C; Lifson JD; Allen TM; Carrington M; Altfeld M
J Exp Med; 2007 Nov; 204(12):3027-36. PubMed ID: 18025129
[TBL] [Abstract][Full Text] [Related]
27. Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.
Zaunders J; van Bockel D
Front Immunol; 2013; 4():95. PubMed ID: 23630526
[TBL] [Abstract][Full Text] [Related]
28. HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil.
Silva EM; Acosta AX; Santos EJ; Netto EM; Lemaire DC; Oliveira AS; Barbosa CM; Bendicho MT; Galvão-Castro B; Brites C
Braz J Infect Dis; 2010; 14(5):468-75. PubMed ID: 21221475
[TBL] [Abstract][Full Text] [Related]
29. The role genes encoding of killer cell immunoglobulin-like receptors (KIRs) and their ligands in susceptibility to and progression of HIV infection.
Błachowicz O; Zwolińska K
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1409-1423. PubMed ID: 28100849
[TBL] [Abstract][Full Text] [Related]
30. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
31. NKG2C
Ma M; Wang Z; Chen X; Tao A; He L; Fu S; Zhang Z; Fu Y; Guo C; Liu J; Han X; Xu J; Chu Z; Ding H; Shang H; Jiang Y
Front Immunol; 2017; 8():1176. PubMed ID: 28979268
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
[TBL] [Abstract][Full Text] [Related]
33. The role of NK cells in HIV-1 protection: autologous, allogeneic or both?
Hens J; Jennes W; Kestens L
AIDS Res Ther; 2016; 13():15. PubMed ID: 26997965
[TBL] [Abstract][Full Text] [Related]
34. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
[TBL] [Abstract][Full Text] [Related]
35. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
[TBL] [Abstract][Full Text] [Related]
36. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
37. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
Pietra G; Romagnani C; Moretta L; Mingari MC
Curr Pharm Des; 2009; 15(28):3336-44. PubMed ID: 19860683
[TBL] [Abstract][Full Text] [Related]
38. HLA-B leader genotypes in a clinical population.
Balgansuren G; Sprague M; Peterson P; Shenavar Y; Ng A; Regen L; Shelton N; Petersdorf E
HLA; 2023 Jul; 102(1):44-51. PubMed ID: 36929133
[TBL] [Abstract][Full Text] [Related]
39. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
[TBL] [Abstract][Full Text] [Related]
40. HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease.
Hosseini E; Minagar A; Ghasemzadeh M; Arabkhazaeli A; Ghasemzadeh A
Hum Immunol; 2023 Apr; 84(4):263-271. PubMed ID: 36822912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
